Related Experiment Video
Updated: Aug 12, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
ETS transcription factor ELK3: Molecular insights and translational horizons in cancer (Review)
Zhenzhe Liu1, Zhong Wei2, Zhensheng Li3
1Huankui Academy, Nanchang University, Nanchang, Jiangxi 330031, P.R. China.
Abstract:
Tumorigenesis is a complex multistage process, with its primary regulatory mechanisms involving the interplay of genetic alterations, immune dysfunction and metabolic abnormalities. Transcription factors serve a crucial role in gene expression regulation, participating in various tumor behaviors such as proliferation, metastasis, angiogenesis and drug resistance. Notably, the abnormal activity of transcription factors is closely associated with cancer initiation and progression, and can promote tumor growth, invasion and therapeutic resistance by regulating angiogenesis, epithelial-mesenchymal transition and metastasis-related gene expression. ELK3 belongs to the ETS transcription factor family and the ternary complex factor subfamily. ELK3 participates in multiple molecular biological processes, and is associated with the initiation, progression, invasion and metastasis of various tumors. The present review summarizes the latest research on the structure of ELK3 and its regulation in normal and tumor tissues, focusing on its primary functions in tumors and the signaling pathways involved. Additionally, the diagnostic value of ELK3 as a biomarker and its potential as a target for tumor-specific therapy are explored.
Insights
Transcription factors regulate gene expression and tumor progression. This review explores ELK3's role in tumorigenesis, its diagnostic value as a biomarker, and its potential as a therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Tumorigenesis involves genetic, immune, and metabolic factors.
- Transcription factors are crucial regulators of gene expression and cellular processes.
- Abnormal transcription factor activity is linked to cancer initiation and progression.
Purpose of the Study:
- To review the structure and regulation of ELK3.
- To summarize ELK3's functions in various tumors.
- To explore ELK3's diagnostic and therapeutic potential in cancer.
Main Methods:
- Literature review of ELK3's role in tumorigenesis.
- Analysis of ELK3's involvement in signaling pathways.
- Evaluation of ELK3 as a biomarker and therapeutic target.
Main Results:
- ELK3, an ETS transcription factor, is implicated in tumor initiation, progression, invasion, and metastasis.
- ELK3 regulates key cancer-related processes like angiogenesis and epithelial-mesenchymal transition.
- ELK3 exhibits potential as a diagnostic biomarker and a target for cancer therapy.
Conclusions:
- ELK3 plays a significant role in multiple aspects of tumor development.
- Understanding ELK3's function can lead to novel diagnostic and therapeutic strategies.
- Targeting ELK3 may offer a promising approach for tumor-specific treatment.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
03:37Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
Published on: March 1, 2024
Related Concept Videos
Master Transcription Regulators
General Transcription Factors
Transcription Factors
Transcription Factors
Cell Specific Gene Expression
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA into a...